You are here: Industry Insights > AD

News List

AC Immune, Lilly Announce License and Collaboration Agreement americanpharmaceuticalreview
December 13, 2018
AC Immune and Eli Lilly and Company announced the two companies have signed a license and collaboration agreement to research and develop.....
Concomitant usage of sleeping pills and painkillers is common among people with AD expressbpd
November 20, 2018
One in five people with Alzheimer’s disease (AD) who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland. Concomitant use was more common in comparison persons, but those with AD us
Concomitant usage of sleeping pills and painkillers is common among people with AD expressbpd
November 20, 2018
One in five people with Alzheimer’s disease (AD) who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland. Concomitant use was more common in comparison persons, but those with AD us
Review of Drugs for Alzheimer’s Disease—Lucky Stars, Fallen Stars and Future Stars of Patients Erxiao
February 13, 2018
The pharmaceutical giants that entered early in the field have suffered R&D setbacks and quit, but this does not stop other companies from continuing to seek the light of victory.
Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia americanpharmaceuticalreview
February 12, 2018
These AD trials were part of an extensive clinical trial program exploring the efficacy of compounds which target malfunctioning of specific (glutamatergic) brain circuits as potential new treatments for specific symptoms and traits of mental illness.

Previous page 1 2 3 Next page